Autoliv (ALIV) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
15 Dec, 2025Executive summary
Achieved record third-quarter sales, operating income, and EPS, driven by strong demand and operational efficiencies in Americas, Europe, and Asia, with cost reductions and tariff compensation recovery.
Organic sales growth was 3.9%-4%, with notable outperformance in India, Americas, and Asia ex-China, and strong performance with Chinese OEMs.
Strategic investments in China included a new R&D center, a joint venture with HSAE, and a partnership with CATARC to advance safety technologies and standards.
Margin expansion resulted from operational improvements, supplier compensation, and successful tariff recovery.
Continued significant shareholder returns through increased dividends and share repurchases.
Financial highlights
Q3 2025 net sales reached $2,706 million, up 5.9%-6% year-over-year; gross profit was $522 million (19.3% margin).
Adjusted operating income rose 14% to $271 million (10.0% margin); operating income up 18% to $267 million.
Adjusted diluted EPS grew 26% to $2.32; diluted EPS up 31% to $2.28.
Operating cash flow was $258 million, up 46% year-over-year; free operating cash flow reached $153 million.
Dividend per share increased 21% to $0.85; $100 million in share repurchases in Q3.
Outlook and guidance
Full-year 2025 guidance: organic sales growth around 3%, adjusted operating margin 10-10.5%, operating cash flow ~$1.2 billion, and capex at ~4.5% of sales.
Global light vehicle production expected to grow 1.5% in 2025; Q4'25 expected to be the strongest quarter with continued outperformance in China and India.
Assumes no major changes in tariffs, trade restrictions, or macroeconomic environment for the remainder of 2025.
Latest events from Autoliv
- Profitability rose despite lower sales; 2024 guidance cut, but H2 margin and cash flow to improve.ALIV
Q2 20243 Feb 2026 - Record sales, margin expansion, and strong cash flow driven by growth in China and India.ALIV
Q4 20252 Feb 2026 - Q3 2024 outperformed global LVP, maintained margins, and reaffirmed strong 2024 guidance.ALIV
Q3 202419 Jan 2026 - Record profit and margin expansion in Q4 2024; 2025 targets higher returns amid risks.ALIV
Q4 20249 Jan 2026 - Record Q2 results, raised guidance, and major shareholder return initiatives announced.ALIV
Q2 202515 Dec 2025 - Q1 2025 saw record EPS, margin gains, and resilient sales growth amid global headwinds.ALIV
Q1 202515 Dec 2025 - 2025 proxy covers director elections, executive pay, auditor ratification, and major ESG progress.ALIV
Proxy Filing2 Dec 2025 - Definitive additional proxy materials filed for proxy voting under SEC rules.ALIV
Proxy Filing2 Dec 2025 - All proposals passed, directors elected, and no shareholder questions or new business raised.ALIV
AGM 202525 Nov 2025